Author:
McCloskey E,Selby P,de Takats D,Bernard J,Davies M,Robinson J,Francis R,Adams J,Pande K,Beneton M,Jalava T,Löyttyniemi E,Kanis J.A
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference34 articles.
1. Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Moskell, W. L., Marcus, R., Ott, S. M., Torner, J. C., Quandt, S. A., Reiss, T. F., Ensrud, K. E. for the Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541; 1996.
2. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on involutional osteoporosis in women. European Agency for the Evaluation of Medicinal Products, London (CPMP/EWP/552/95); 1997.
3. Cummings, S. R., Black, D. M., Thompson, D. E., Applegate, W. B., Barrett-Connor, E., Muslimer, T. A., Palermo, L., Prineas, R., Rubin, S. M., Scott, J. C., Vogt, T., Wahau, R., Yates, A. J., Lacroix, A. Z. for the Fracture Intervention Trial Research Group. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 280:2077–2082; 1998.
4. Esophagitis associated with the use of alendronate;De Groen;N Engl J Med,1996
5. Delmas, P. D., Chapuy, M. C., Vignon, E., Charhon, S., Briancon, D., Alexandre, C., Edouard, C., and Meunier, P. J. Long term effects of dichloromethylene diphosphonate in Paget’s disease of bone. J Clin Endocrinol Metab 54:837–844; 1982a.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献